## **Core Concept**
The question tests knowledge of Angiotensin II receptor blockers (ARBs) and their effects beyond blood pressure control, specifically antiplatelet activity. ARBs are a class of drugs used to treat hypertension and heart failure by blocking the action of angiotensin II at its receptor. They are known for their protective effects on the cardiovascular system.

## **Why the Correct Answer is Right**
Losartan, one of the ARBs listed, is known to have a unique property among its class: it exhibits antiplatelet activity. This effect is attributed to its ability to antagonize the P2Y12 receptor on platelets, in addition to its angiotensin II type 1 (AT1) receptor blocking activity. The P2Y12 receptor plays a critical role in platelet activation and aggregation. By blocking this receptor, losartan can help reduce the risk of thrombotic events.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Candesartan primarily works by selectively blocking the AT1 receptor without significant effects on the P2Y12 receptor or notable antiplatelet activity.
- **Option B:** Valsartan is another potent ARB that mainly acts on the AT1 receptor but does not have significant antiplatelet effects through P2Y12 receptor antagonism.
- **Option D:** Telmisartan, like other ARBs, primarily blocks the AT1 receptor and does not have a notable antiplatelet action through the P2Y12 receptor.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while losartan has been associated with antiplatelet activity, this effect is not a characteristic shared by all ARBs. Losartan's dual action on both the AT1 receptor and the P2Y12 receptor makes it somewhat unique in its class for this particular benefit.

## **Correct Answer:** . Losartan